Skip to main content
. 2023 Mar 4;15(3):e35751. doi: 10.7759/cureus.35751

Table 1. Characteristics of study participants.

All variables are reported as n (%) unless otherwise stated.

BMI: body mass index; SCD: sickle cell disease; G6PD: glucose 6 phosphatase dehydrogenase; Hb: hemoglobin; MCV: mean corpuscular volume; LDL: lactate dehydrogenase; AST: aspartate transaminase

 Demographic Variables n=54
Age, mean (SD) (years) 11.9 (3.48)
BMI, mean (SD) 17.54 (3.62)
Gender
Female 18 (33.3)
Male 36 (66.7)
Age at diagnosis of SCD, mean (SD) (years) (n=51) 3.49 (2.92)
Genotype
HbSS-HbSB0 51 (94.4)
Others 3 (5.6)
SCD severity
Mild-moderate 35 (64.83)
Severe 19 (35.2)
Comorbidities
Hyperactive airway disease
No 37 (68.5)
Yes 17 (31.5)
G6PD deficiency
No 49 (90.7)
Yes 5 (9.3)
Baseline Hematological Parameters
Hb level, mean (SD) (g/dl) 8.70 (1.56)
HbS %, mean (SD) 74.15 (8.87)
HbF %, mean (SD) 20.30 (9.03)
HbA %, mean (SD) 1.17 (4.97)
HbA2 %, mean (SD) 3.11 (1.04)
MCV, mean (SD) (fl) 83.97 (11.97)
Hemolytic Parameters
LDL, mean (SD) (u/l) (n=51) 449.75 (197.40)
Reticulocyte percentage, mean (SD) 10.79 (7.51)
Bilirubin, mean (SD) (umol/l) (n=52) 41.34 (46.51)
AST, mean (SD) (u/l) (n=52) 39.38 (12.78)